title: [Polyuropolydipsic syndromes].
abstract: CONCLUSIONS
  Intracellular dehydration is the major risk in case of a polyuropolydipsic syndrome. Excepting osmotic polyuria, prognosis depends on a possibly progressive functional anomaly of the hypothalamopituitary axis.
  
  
  METHODS
  Polyuropolydipsia occurs when antidiuretic hormone (ADH) secretion is absent (central diabetes insipidis), the kidney does not respond to ADH (nephrogenic diabetes insipidus) or in case of physiological inhibition of ADH secretion (primary polydipsia).
  Dynamic explorations are associated with radioimmunoassay of ADH. They are particularly useful in case of atypical diabetes insipidus and include the water restriction test and a study of the sensitivity to exogenous ADH (dDAVP). The results orient the etiologic diagnosis and allow an evaluation of the fluid intake required as a function of the maximal concentrating capacity of the kidneys.
  Treatment is based on ADH analogs (dDAVP). The aim is to obtain a constant antidiuretic effect without hyponatremia or escape. In case of partial central diabetes insipidus, a non-hormone treatment using compounds which increase vasopressin release or its effect on the kidney can be proposed.
authors.affiliation: Service d'Explorations fonctionnelles, Hôpital Tenon, Paris.
authors.forename: B
authors.initials: B
authors.lastname: Fouqueray
authors.forename: F
authors.initials: F
authors.lastname: Paillard
authors.forename: L
authors.initials: L
authors.lastname: Baud
mesh_terms: D003937:Diagnosis, Differential; D004326:Drinking; D006801:Humans; D009994:Osmolar Concentration; D011141:Polyuria / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013577:Syndrome; D013894:Thirst; D014667:Vasopressins / Q000502:physiology*
chemical_list: D014667:Vasopressins